Malignant Neoplasm of the Breast B019
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-breast-b019-c50d05
Rulebase for malignant neoplasm of the breast
<h5><strong>Current RMA Instruments</strong></h5><table border="1" cellpadding="0" cellspacing="1" width="100%"><tbody><tr><td><p><em><u><a href="http://www.rma.gov.au/assets/SOP/2023/a5acf4f5e0/084.pdf" target="_blank">Reasonable Hypothesis SOP</a></u></em></p></td><td><p>84 of 2023 as amended</p></td></tr><tr><td><p><em><u><a href="http://www.rma.gov.au/assets/SOP/2023/db8fec7972/085.pdf" target="_blank">Balance of Probabilities SOP</a></u></em></p></td><td><p>85 of 2023 as amended</p></td></tr></tbody></table><h5><strong>Changes from previous Instruments</strong></h5><p><strong><drupal-media data-entity-type="media" data-entity-uuid="5a467c37-bc20-4b5d-b973-c2e2e496d10b" data-view-mode="wysiwyg"></drupal-media></strong></p><h5>ICD Coding</h5><ul><li>ICD-10-AM Codes: C50, D05</li></ul><h5><strong>Brief description</strong></h5><p>This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.</p><h5><strong>Confirming the diagnosis</strong></h5><p>Diagnosis requires histology from a biopsy or surgical specimen.</p><p>The appropriate medical specialist is an oncologist or breast surgeon.</p><h5><strong>Additional diagnoses covered by SOP</strong></h5><ul><li>Breast adenocarcinoma</li><li>Breast carcinoma in situ – ductal, intraductal or lobular</li><li>Infiltrating ductal breast carcinoma</li><li>Metastatic breast cancer from a breast primary</li><li>Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary</li><li>Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast</li></ul><h5><strong>Conditions excluded from SOP </strong></h5><ul><li>Carcinoid tumour of the breast <sup>#</sup></li><li>Hodgkin's lymphoma of the breast *</li><li>Malignant neoplasm of the skin overlying the breast<ul><li>melanoma *</li><li>non-melanitic *<!-- --></li></ul></li><li>non-Hodgkin lymphoma of the breast *</li><li>Secondary metastasis to the breast (code to primary site)</li><li>Soft tissue sarcoma of the breast *</li></ul><p>* another SOP applies</p><p><sup>#</sup> non-SOP condition</p><h5><strong>Clinical onset</strong></h5><p>Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.</p><h5><strong>Clinical worsening</strong></h5><p>The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.</p><h5> </h5><h5> </h5>
Source URL: https://clik.dva.gov.au/sop-information/sops-and-supporting-information-alphabetic-listing/m/malignant-neoplasm-breast-b019/rulebase-malignant-neoplasm-breast
A course of therapeutic radiation to the chest
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/course-therapeutic-radiation-chest
Alcohol consumption
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/alcohol-consumption
Atomic radiation
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/atomic-radiation
Cessation of breast feeding
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/cessation-breast-feeding
Diagnostic radiation to the breast
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/diagnostic-radiation-breast
First live birth or full-term pregnancy after age 30
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/first-live-birth-or-full-term-pregnancy-after-age-30
Hormone replacement therapy
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/hormone-replacement-therapy
Inability to obtain appropriate clinical management for breast cancer
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/inability-obtain-appropriate-clinical-management-breast-cancer
Inability to undertake any physical activity greater than 3 METs
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/inability-undertake-any-physical-activity-greater-3-mets
Nulliparous to age 30 years or over
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/nulliparous-age-30-years-or-over
Obesity
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/obesity
Taking oral contraceptives
Current RMA Instruments
84 of 2023 as amended | |
85 of 2023 as amended |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: C50, D05
Brief description
This SOP covers primary malignant neoplasms of breast epithelial tissue. Note that this SOP applies to males as well as females.
Confirming the diagnosis
Diagnosis requires histology from a biopsy or surgical specimen.
The appropriate medical specialist is an oncologist or breast surgeon.
Additional diagnoses covered by SOP
- Breast adenocarcinoma
- Breast carcinoma in situ – ductal, intraductal or lobular
- Infiltrating ductal breast carcinoma
- Metastatic breast cancer from a breast primary
- Other histological breast carcinoma types – invasive lobular; ductal/lobular; mucinous; tubular; medullary; or papillary
- Paget’s disease of the breast. This is a breast carcinoma of the nipple of the breast
Conditions excluded from SOP
- Carcinoid tumour of the breast #
- Hodgkin's lymphoma of the breast *
- Malignant neoplasm of the skin overlying the breast
- melanoma *
- non-melanitic *
- non-Hodgkin lymphoma of the breast *
- Secondary metastasis to the breast (code to primary site)
- Soft tissue sarcoma of the breast *
* another SOP applies
# non-SOP condition
Clinical onset
Clinical onset will generally be when a breast lump (subsequently confirmed to be a breast cancer) is first found or when a screening mammogram first shows evidence of the condition.
Clinical worsening
The only SOP worsening factor is for inability to obtain appropriate clinical management. The disease has a very variable course and prognosis. It is particularly amenable to treatment if found early. A delay in appropriate treatment could result in worsening of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-breast-b019-c50d05/rulebase-malignant-neoplasm-breast/taking-oral-contraceptives